← Leaderboards
Ralph A Bradshaw
Cedars-Sinai Medical Center
$911,869
Attributed
$911,869
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$911,869 · 4
By mechanism
R01$560,388 · 2
P01$344,983 · 1
P41$6,498 · 1
Top collaborators
No co-investigators on record.
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Mitchell Kronenberg$46,508,740
- David R Eyre$521,961
- Kenneth E Bernstein$19,603,058
Others in their field
Top investigators on “Pc12 Cells”
- Thomas F Martin · University Of Wisconsin Madison$9,471,840
- James E Rothman · Sloan-Kettering Institute For Cancer Res$6,294,229
- Stefan Strack · University Of Iowa$5,701,616
- Xiao-Jiang Li · Emory University$5,260,191
- Lloyd A Greene · Columbia University Health Sciences$4,867,903
- Isaac T Schiefer · University Of Toledo Health Sci Campus$4,412,394
Research focus
Pc12 CellsEnzyme ActivityCell DifferentiationPosttranslational ModificationsChimeric ProteinsSite Directed MutagenesisProtein Structure FunctionGrowth Factor ReceptorsAchondroplasiaAcyltransferaseImmunoprecipitationIsozymesConfocal Scanning MicroscopyCongenital Skeletal DisorderAminopeptidaseEnzyme StructureEnzyme MechanismAminohydrolasesGene MutationActive SitesEnzyme SubstrateCell Growth RegulationFibroblast Growth FactorBone Development Disorder
Grant awards (7)
POSTTRANSLATIONAL MODIFICATION OF ROR2$24
P41 · FY2005 · RR
POSTTRANSLATIONAL MODIFICATION OF ROR2$6,474
P41 · FY2004 · RR
COTRANSLATIONAL PROCESSING AND PROTEIN TURNOVER$235,690
R01 · FY2001 · DK
MOLECULAR ANALYSIS OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 MUTATIONS$176,978
P01 · FY2001 · HD
COTRANSLATIONAL PROCESSING AND PROTEIN TURNOVER$230,599
R01 · FY2000 · DK
MOLECULAR ANALYSIS OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 MUTATIONS$168,005
P01 · FY2000 · HD
STRUCTURE AND FUNCTION OF NERVE GROWTH FACTOR$94,099
R01 · FY2000 · AG